l-carnitine and opioid tolerance in Critical Illness Assessment of experimental opioid tolerance.
Description
Participants received doses of 5 mg NAP ( n = 22), 30 mg NAP ( n = 22), or placebo ( n = 25) for a period of 12 weeks
Immune suppressive mechanisms in the tumor microenvironment
Kann O, Papageorgiou IE, Draguhn A
Commission CP
These intertwined factors potentially maintain a disturbed homeostasis within individuals suffering from ME/CFS
